Cardiovascular safety of mirabegron in individuals treated for spinal cord injury- or multiple sclerosis-induced neurogenic detrusor overactivity

Autor: Jan Mokriš, Renata Cifkova, Jan Krhut, Vladimír Borovička, Radek Sýkora, Peter Wohlfahrt, Peter Zvara, Eliška Kufová, Jiří Pudich, Karolina Bilkova, Roman Zachoval

Publikováno v: Krhut, J, Wohlfahrt, P, Pudich, J, Kufová, E, Borovička, V, Bílková, K, Sýkora, R, Mokriš, J, Cífková, R, Zachoval, R & Zvara, P 2021, ' Cardiovascular safety of mirabegron in individuals treated for spinal cord injury-or multiple sclerosis-induced neurogenic detrusor overactivity ', International Urology and Nephrology, vol. 53, no. 6, pp. 1089-1095 . https://doi.org/10.1007/s11255-020-02774-7

Purpose: To analyze cardiovascular safety of mirabegron in patients with spinal cord injury (SCI)- and multiple sclerosis (MS)-induced neurogenic detrusor overactivity (NDO) in a prospective, randomized, double-blind, placebo-controlled study. Method

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3de889cec4abf0e08f5cfa71ea100dfc
https://doi.org/10.1007/s11255-020-02774-7